Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Aiding in the diagnosis of neurosyphilis
If this test is positive, a VDRL titer will be performed at an additional charge.
See Meningitis/Encephalitis Panel Algorithm in Special Instructions.
VDRL is a nontreponemal serologic test for syphilis that uses a cardiolipin-cholesterol-lecithin antigen to detect reaginic antibodies. The VDRL test performed on cerebrospinal fluid (CSF) can be used to diagnose neurosyphilis in patients with a prior history of syphilis infection.
The presence of neurosyphilis in untreated patients can be detected by the presence of pleocytosis, elevated protein, and a positive VDRL.
Negative
Reference values apply to all ages.
A positive VDRL result on spinal fluid is highly specific for neurosyphilis.
A single negative VDRL result should not be used to exclude neurosyphilis and repeat testing on a new specimen may be necessary.
Positive results will be titered.
VDRL testing on spinal fluid gives a high percentage of false-negatives.
1. Miller JN: Value and limitations of nontreponemal and treponemal tests in the laboratory diagnosis of syphilis. Clin Obstet Gynecol. 1975;18:191-203
2. Radolf JD, Tramont EC, Salazar JC: Syphilis (Treponema pallidum). In Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2020:2865-2892